What Neocutis does

Neocutis operates a hybrid go-to-market model combining professional/physician-dispensed sales (through dermatologists, aestheticians, medical spas, and a Find a Provider network) with direct-to-consumer e-commerce via store.neocutis.com and authorized retailers including Amazon, Dermstore, Dermwarehouse, LovelySkin, and other specialty skincare platforms. Products are sold as one-time purchases with no disclosed subscription model; pricing is not publicly disclosed and varies by channel. The company is a brand owned by Merz North America, Inc., a subsidiary of Merz Pharma GmbH & Co. KGaA, with trademarks (NEOCUTIS, LUMIÈRE, NOUVELLE+, RÉACTIVE, MELAPLEX, HYALIS) held by Anteis S.A. and NEO THERAPY held by Merz North America. Operations and website content are restricted to US residents, with brand headquarters effectively at Merz North America's Raleigh, NC office and R&D heritage tied to Lausanne, Switzerland.

Name

Neocutis

Legal name

Neocutis (brand owned by Merz North America, Inc.)

Website

https://neocutis.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

11–50 employees

Short description

Neocutis is a US medical-grade anti-aging skincare brand owned by Merz North America, offering 18+ growth-factor and peptide-based products sold through physicians and direct-to-consumer e-commerce for anti-aging and post-procedure care.

Ownership category

akta.pro rank

Product category

Medical-Grade Anti-Aging Skincare

NAICS

Health and Personal Care Retailers (4561), Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics (2840)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK), Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Eye & Lip Skincare (CRABAAAC)

Keywords

• Medical-grade skincare
• Anti-aging skincare
• Growth factor skincare
• Proprietary peptide skincare
• Post-procedure skincare

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Marketing or Sales, Supply Chain, Operations, Personnel

Revenue model

1. Direct Product Sales: Neocutis generates revenue through direct-to-consumer sales of medical-grade skincare products via their e-commerce store and authorized retail partners. Products are sold as one-time purchases with no subscription model mentioned. Revenue is driven by a portfolio of 18+ SKUs spanning cleansers, serums, creams, masks, and SPF products targeting anti-aging concerns.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Neocutis develops and sells a portfolio of medical-grade anti-aging skincare products formulated around proprietary Human Growth Factors (PSP) and Proprietary Peptide (MPC) technologies. The 18-product line spans cleansers, serums, day/night creams, eye creams, body care, post-procedure support, biocellulose masks, and broad-spectrum SPF products designed to address fine lines, wrinkles, loss of firmness, hyperpigmentation, redness, and post-procedure recovery for individual consumers and post-procedure patients.

Product overview

Neocutis is a medical-grade anti-aging skincare brand owned by Merz North America, Inc. The portfolio centers on two proprietary technology platforms—Human Growth Factors and Proprietary Peptides—along with specialized enhancer technologies including MELAPLEX (skin brightening), HYALURONATE (hydration), VITAPLEX C (antioxidant), and ROSAPLEX (redness reduction). The product line includes five core 'Firm Five' products (Bio Serum Firm, Bio Cream Firm, Lumière Firm, Journee Firm Riche, and Neo Firm) supplemented by targeted treatments for specific concerns: cleansers (Neo Cleanse Exfoliating and Gentle), hydration boosters (Hyalis+), eye creams (Lumière Firm and Lumière Firm Riche), body care (Neo Body), post-procedure support (Aftercare, Neo Restore Masks, Neo Therapy), and corrective treatments (Nouvelle+ with retinol, Perle for brightening, RéACTIVE+ for sun protection). Products address concerns including fine lines/wrinkles, dark circles, sagginess, dullness, redness, dryness, skin discoloration, and oxidative stress. The regimen builder tool helps consumers create personalized routines based on skin type and concerns.

Differentiator

Problem solved

Functional benefit

Brands

• MELAPLEX: Proprietary, award-winning skin-brightening complex for hyperpigmentation
• HYALURONATE
• VITAPLEX C
• ROSAPLEX

Products and services

• AFTERCARE Post-treatment soothing cream that helps boost collagen, hydrate, nurture, and soothe healing skin to promote post-procedure care. Contains growth factors, lipids, Wild Yam Root Extract, and proprietary proteins. For patients recovering from cosmetic or dermatological procedures.
• BIO CREAM FIRM Anti-aging moisturizer with growth factors and proprietary peptides. Supports collagen and elastin production, improves skin tone and texture, and addresses fine lines, wrinkles, sagginess, and redness. For consumers seeking visible anti-aging benefits in as little as 14 days.
• BIO CREAM FIRM RICHE Rich, emollient version of Bio Cream Firm formulated for mature skin. Renews skin suppleness, helps smooth lines and wrinkles, and addresses dryness, redness, and post-treatment skin.
• BIO GEL FIRM Lightweight oil-free hydrogel formulation designed for oily or acne-prone skin. Provides skin-plumping hydration, supports collagen and elastin production, and improves skin tone and texture.
• BIO SERUM FIRM Rejuvenating growth factor and peptide treatment serum. Proprietary peptides support collagen and elastin production while human growth factors diminish fine lines and wrinkles, refine texture, brighten skin tone, improve firmness and elasticity, and boost hydration. Demonstrated results in as few as 6 days.
• HYALIS+ Intensive hydrating serum with multiple types of pure Sodium Hyaluronate. Oil-free formulation promotes smooth, soft, supple skin and minimizes the appearance of fine lines and wrinkles.
• JOURNÉE FIRM RICHE Extra moisturizing revitalizing and refining day cream with broad-spectrum SPF 30 sun protection. Combines growth factors, proprietary peptides, and an antioxidant blend for anti-aging protection and hydration.
• LUMIÈRE FIRM Illuminating and tightening eye cream targeting the delicate eye area. Human growth factors and proprietary peptides reduce fine lines, wrinkles, crow's feet, puffiness, and under-eye darkness in 14 days.
• LUMIÈRE FIRM RICHE Extra moisturizing illuminating and tightening eye cream for mature skin. Luxurious emollient version with trio of emollients that lock in moisture and improve skin's moisture retention.
• NEO BODY Restorative body cream targeting body skin aging. Proprietary peptides enhance natural collagens, while ceramides, phytosphingosine, and cholesterol restore damaged dry skin. Salicylic acid exfoliates to minimize rough bumpy patches.
• NEO CLEANSE EXFOLIATING 9.9% Glycolic Acid gel cleanser that exfoliates skin to reveal a fresh, vibrant complexion. Formulated without harsh sulfates, dyes, or fragrances. Ideal for preparing skin for procedures.
• NEO CLEANSE GENTLE Gentle skin soothing gel cleanser that washes away makeup and surface impurities. Ideal for dry skin, post-procedure cleansing, and redness-prone skin.
• NEO FIRM Advanced neck and décolleté firming cream with proprietary peptides. Helps firm and tighten skin, supports collagen and elastin restoration, and diminishes age spots and uneven skin tone.
• NEO RESTORE MASKS Biocellulose sheet masks packed with proprietary peptides and hyaluronic acid. First Neocutis post-treatment mask designed to soothe, brighten, and retexturize skin. Works from Day 1 with visible improvements.
• NEO THERAPY Neck and décolleté treatment designed to support results of Ultherapy treatments with added skin brightening benefit. Helps firm, tighten, and diminish age spots. NEO THERAPY is a registered trademark of Merz North America, Inc.
• NOUVELLE+ Retinol correction cream (0.7%) with hydroquinone-free MELAPLEX technology. Helps reduce fine lines, wrinkles, and dark spots, and improves skin brightness and radiance.
• PERLE Skin brightening and discoloration corrector with patent-pending MELAPLEX technology. Targets hyperpigmentation and uneven skin tone with four cosmetic ingredients. Improves skin tone by 43% after 12 weeks.
• RÉACTIVE+ Antioxidant serum with broad-spectrum SPF 45. VITAPLEX C technology combines 15% stabilized Vitamin C with Vitamin E and EGCG to neutralize free radicals and minimize oxidative stress.

Quantifiable outcome

• 180% boost in Collagen I production
• +7 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered minor and core.

• UltherapyminorStrategic or Co-development PartnerNeocutis Neo Therapy product is specifically designed to support Ultherapy neck and décolleté treatments. Ultherapy is the only FDA-cleared non-invasive procedure with real-time visualization that lifts the neck, chin, and brow, and improves lines and wrinkles on the upper chest. The partnership provides complementary post-treatment care for Ultherapy patients.
• Merz North America, Inc.coreOthersNeocutis is a brand owned and operated by Merz North America, Inc., a company committed to providing accessible and inclusive digital experiences. Merz Aesthetics holds the brand portfolio including registered trademarks for Neocutis products.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• EltaMD: Medical-grade skincare brand owned by Colgate-Palmolive, with broad SPF and post-procedure offerings sold through physicians and DTC. Overlaps with Neocutis on medical-grade positioning and post-procedure use cases, with a stronger mass SPF footprint.
• Obagi Medical: Long-standing medical-grade skincare brand focused on anti-aging, hyperpigmentation, and physician-channel sales. Comparable to Neocutis in targeting concerns like discoloration and wrinkles, with a broader legacy product portfolio and stronger retail/DTC presence.
• SkinCeuticals: Medical-grade skincare brand owned by L'Oréal, one of the largest physician-channel skincare companies globally. Competes with Neocutis across antioxidant, anti-aging, and post-procedure segments but with a much broader portfolio and global footprint.

Direct peers

• SkinMedica: Physician-dispensed medical-grade skincare brand owned by Allergan Aesthetics (AbbVie). Closely comparable to Neocutis in channel (medical professionals + DTC), category positioning (anti-aging, post-procedure), and evidence-led marketing with proprietary ingredient platforms.
• Revision Skincare: Professional skincare brand sold through medical aesthetic practices, with peptide-led and post-procedure products. Directly comparable to Neocutis on physician-dispensed distribution, anti-aging technology, and aesthetic-practice channel focus.
• ZO Skin Health: Physician-dispensed medical-grade skincare brand founded by Dr. Zein Obagi, focused on anti-aging, hyperpigmentation, and corrective regimens. Directly comparable to Neocutis on physician channel, treatment positioning, and regimen-based offering.
• PCA Skin: Professional skincare brand sold through licensed skincare professionals, with chemical peels, post-procedure, and anti-aging lines. Comparable to Neocutis on professional channel, regimen-based selling, and clinical-product positioning.
• iS Clinical: Medical-grade cosmeceutical brand distributed through physicians, spas, and DTC, focused on actives and clinical skincare. Comparable positioning to Neocutis in physician channel, anti-aging emphasis, and clinically backed formulations.
• Alastin Skincare: Physician-dispensed medical-grade skincare brand owned by Galderma, built around proprietary peptide and post-procedure platforms. Direct overlap with Neocutis on growth factors/peptides, post-procedure use cases, and aesthetic practice distribution.

Emerging players

• Colorescience: Physician-recommended mineral-based skincare and sun protection brand. Adjacent to Neocutis in medical-grade channel and aesthetic practice distribution, with stronger SPF/color positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/neocutis
• Xx.com/neocutis
• Facebookfacebook.com/neocutisinc
• LinkedInlinkedin.com/company/neocutis-s-a-

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neocutis